Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace). (linkinghub.elsevier.com)

Authors: Bonten M … Cohen KA Journal: Lancet Infectious Diseases Published: 2026-10-12 DOI: https://doi.org/10.1016/S1473-3099(26)00469-X